MetLife, Inc.'s (MET) shares have seen significant movements with several investors and institutions making decisions. Wedge Capital Management and Swiss National Bank have sold their MET shares, while SG Americas Securities, Wellington Management Group and others have increased their holdings. Q4 Earnings have been in the spotlight, leading to various opinions about whether MET is undervalued or not. Keefe, Bruyette & Woods reinstated MET's outperform rating, while TD Cowen lowered the target price but retained a buy rating. Dividend announcements have kept the sentiment strong. MET has also seen executive movements like Jordan Canter being named Head of Federal Government Affairs and Regulatory Policy. Forecasts indicate that MET's Cheap Valuation and AI insights may impact investors. Despite a Q4 CY2025 revenue, the company's 2026 outlook is believed to potentially alter investment perspectives. MET's MetLife Investment Management (MIM) segment and capital returns are expected to reshape its core investment narrative. MET share buybacks amidst lower Q3 earnings may get varied investor response. An intriguing factor is MET's mass annuity risk transfer, anticipated to be a potential game changer. Looking forward Mets is recommending shareholders to reject Potemkin Limited's 'Mini-Tender' offer.
Metlife MET News Analytics from Tue, 29 Jul 2025 07:00:00 GMT to Sat, 28 Mar 2026 12:18:33 GMT -
Rating 2
- Innovation -4
- Information 7
- Rumor -8
